Immunovant, Inc. - 10-Q Filing

Immunovant, Inc. reports quarterly results for the period ended September 30, 2026, with 206.9 million shares of common stock outstanding as of November 3, 2026.

SEC EDGAR · November 9, 2026, 12:20 UTC

Tickers: $IMVT

Read the full article at SEC EDGAR

More Regulatory news

NVIDIA CORP - 8-K Filing SEC EDGAR · November 12, 2026, 13:52 UTC
COVENANT LOGISTICS GROUP, INC. - 8-K Filing SEC EDGAR · November 12, 2026, 13:52 UTC
CuriosityStream Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 13:52 UTC
Star Equity Holdings, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:52 UTC
DeFi Development Corp. - 10-Q Filing SEC EDGAR · November 12, 2026, 13:51 UTC
BALTIC INTERNATIONAL USA INC - 10-Q Filing SEC EDGAR · November 12, 2026, 13:49 UTC
Forbright, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:50 UTC
Boxlight Corp - 8-K Filing SEC EDGAR · November 12, 2026, 13:50 UTC
CuriosityStream Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:49 UTC
BORGWARNER INC - 8-K Filing SEC EDGAR · November 12, 2026, 13:47 UTC